Case Report: Long-term survival of a patient with advanced rectal cancer and multiple pelvic recurrences after seven surgeries
BackgroundRectal cancer has a high risk of recurrence and metastasis, with median survival ranging from 24 months to 36 months. K-RAS mutation is a predictor of poor prognosis in rectal cancer. Advanced rectal cancer can be stopped in its tracks by pelvic exenteration.Case summaryA 51-year-old woman...
Main Authors: | Ye Ouyang, Yilin Zhu, Haoyi Chen, Guoquan Li, Xiongwei Hu, Hongyu Luo, Zhou Li, Shuai Han |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-05-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1169616/full |
Similar Items
-
Is total pelvic exenteration suitable for elderly patients with locally advanced or recurrent rectal cancer?
by: Nicolae BACALBASA, et al.
Published: (2021-06-01) -
Pelvic exenteration and composite sacral resection in the surgical treatment of locally recurrent rectal cancer
by: Wael Gawad, et al.
Published: (2014-09-01) -
Total pelvic exenterations in patients with locally advanced primary and recurrent rectal tumors: possibilities of urinary tract reconstruction
by: B. Ya. Alekseyev, et al.
Published: (2015-02-01) -
Salvage Total Pelvic Exenteration with Bilateral V-Y Advancement Flap Reconstruction for Locally Recurrent Rectal Cancer
by: Jo Tashiro, et al.
Published: (2013-03-01) -
Association between pelvic exenteration and hyperthermic intraperitoneal chemotherapy for rectal cancer
by: Nicolae Bacalbasa, et al.
Published: (2021-06-01)